Join
Live feed
·
INSIDERFilingvia Quantisnow
Jazz Pharmaceuticals plc logo

EVP, Global Head of R&D & CMO Iannone Robert sold $19,207,098 worth of Ordinary Shares (76,921 units at $249.70) as part of a pre-agreed trading plan and exercised 57,500 units of Ordinary Shares at a strike of $125.84, decreasing direct ownership by 23% to 65,686 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JAZZ (Jazz Pharmaceuticals plc) and more on Quantisnow.